drugset / Trial / NCT03903653

Botulinum Toxin A & Weekly Serial Casting in ABI Inpatients With Lower Extremity Spasticity

NCT03903653

RandomizedParallel-groupTriple-blindTreatment

Summary

Effects of Chemodenervation (Botulinum Toxin A) and Serial Casting vs Botulinum Toxin A and without serial casting in Lower Limb Spasticity following ABI.

Timeline

Start
2019-09-01
Primary completion
2019-11-01
Completion
2019-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin type A Protein / enzyme biologic 350 iu
Comparator Botulinum toxin type A Protein / enzyme biologic 400 iu

Indications

No indication recorded.